EQA Scheme
Contact
Virus Immunology - SARS-CoV-2 (Ab) (416)
Samples:
4 samples of 0.5 ml
Sample properties:
Liquid serum/plasma
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
not applicable
Certificate Validity: not applicable
Not subject to Rili-BÄK
Parameters:
Anti-SARS-CoV-2 IgA (not certified), Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgG avidity (not certified), Anti-SARS-CoV-2 IgM (not certified), Anti-SARS-CoV-2 Surrogate neutralizing antibodies , Anti-SARS-CoV-2 total (without differentiation of IgG, IgA and IgM)
Certificate Validity: 12 months
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| Mar. (2) | June (4) | Sep. (5) | Nov. (6) |
|---|---|---|---|
| 08.01.2027 | 09.04.2027 | 25.06.2027 | 03.09.2027 |
| 09.03.2027 | 08.06.2027 | 24.08.2027 | 02.11.2027 |
| 26.03.2027 | 25.06.2027 | 10.09.2027 | 19.11.2027 |
EQAS/PT Experts:
Dr. med. Martin Obermeier
MVZ medizinisches Infektiologiezentrum Berlin AG
Oudenarder Strasse 16
13347 Berlin
+49 30-34409104-66
obermeier@mvz-mib.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de